Menú

GRenSSAP
GRenSSAP

Responsable del grupo
avatar_investigadors.jpg
Anna Berenguera Ossó
avatar_grups_recerca.png

Publicaciones

Endometriosis prevalence and incidence trends in a large population-based study in Catalonia (Spain) from 2009 to 2018

L. MEDINA-PERUCHA, A. PISTILLO, B. RAVENTOS, C. JACQUES-AVINO, J. MUNROS-FELIU, C. MARTINEZ-BUENO, C. VALLS-LLOBET, F. CARMONA, T. LOPEZ-JIMENEZ, G. PUJOLAR-DIAZ, E. ARCAS, A. BERENGUERA and T. DUARTE-SALLES
Womens Health. 2022 Oct 1; . doi:10.1177/17455057221130566; PMID:36281527

Ver más:
Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysis

C. YANG, R. WILLIAMS, J. SWERDEL, J. ALMEIDA, E. BROUWER, E. BURN, L. CARMONA, K. CHATZIDIONYSIOU, T. DUARTE-SALLES, W. FAKHOURI, A. HOTTGENROTH, M. JANI, R. KOLDE, J. KORS, L. KULLAMAA, J. LANE, K. MARINIER, A. MICHEL, H. STEWART, A. PRATS-URIBE, S. REISBERG, A. SENA, C. TORRE, K. VERHAMME, D. VIZCAYA, J. WEAVER, P. RYAN, D. PRIETO-ALHAMBRA and P. RIJNBEEK
SEMINARS IN ARTHRITIS AND RHEUMATISM. 2022 Oct 1; . doi:10.1016/j.semarthrit.2022.152050; PMID:35728447

Ver más:
Residential Proximity to Urban Play Spaces and Childhood Overweight and Obesity in Barcelona, Spain: A Population-Based Longitudinal Study

N. SANCHEZ-VALDIVIA, C. PEREZ-DEL-PULGAR, J. DE BONT, I. ANGUELOVSKI, A. LOPEZ-GAY, A. PISTILLO, M. TRIGUERO-MAS and T. DUARTE-SALLES
International Journal of Environmental Research and Public Health. 2022 Oct 1; . doi:10.3390/ijerph192013676; PMID:36294256

  • Any: 01/10/2022
  • FI: 4.614
  • Article

Ver más:
Multimorbidity worsened anxiety and depression symptoms during the COVID-19 pandemic in Brazil.

Castro-de-Araujo LFS, Rodrigues EDS, Machado DB, Henriques CMP, Verotti MP, Gonçalves AQ, Duarte-Salles T, Kanaan RA, Barreto ML, Lewis G and Barbosa JR
JOURNAL OF AFFECTIVE DISORDERS. 2022 Oct 1; . doi:10.1016/j.jad.2022.07.005; PMID:35810830

Ver más:
International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients.

Nishimura A, Xie J, Kostka K, Duarte-Salles T, Fernández Bertolín S, Aragón M, Blacketer C, Shoaibi A, DuVall SL, Lynch K, Matheny ME, Falconer T, Morales DR, Conover MM, Chan You S, Pratt N, Weaver J, Sena AG, Schuemie MJ, Reps J, Reich C, Rijnbeek PR, Ryan PB, Hripcsak G, Prieto-Alhambra D and Suchard MA
Frontiers in Pharmacology. 2022 Sep 14; . doi:10.3389/fphar.2022.945592; PMID:36188566

Ver más: